Skip to main content
The BMJ logoLink to The BMJ
letter
. 1993 Mar 20;306(6880):797. doi: 10.1136/bmj.306.6880.797

Costs of screening are important.

C Edgell
PMCID: PMC1677228  PMID: 8490365

Full text

PDF

Page 797

797

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowman J. E. Screening newborn infants for Duchenne muscular dystrophy. BMJ. 1993 Feb 6;306(6874):349–349. doi: 10.1136/bmj.306.6874.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bradley D. M., Parsons E. P., Clarke A. J. Experience with screening newborns for Duchenne muscular dystrophy in Wales. BMJ. 1993 Feb 6;306(6874):357–360. doi: 10.1136/bmj.306.6874.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clark A. L., Coats A. J. Screening for hypertrophic cardiomyopathy. BMJ. 1993 Feb 13;306(6875):409–410. doi: 10.1136/bmj.306.6875.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Schröder F. H. Prostate cancer: to screen or not to screen? BMJ. 1993 Feb 13;306(6875):407–408. doi: 10.1136/bmj.306.6875.407. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES